Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Screening and characterization of molecules that modulate the biological activity of IFNs-I.

Bürgi M, Zapol'skii VA, Hinkelmann B, Köster M, Kaufmann DE, Sasse F, Hauser H, Etcheverrigaray M, Kratje R, Bollati-Fogolín M, Oggero M.

J Biotechnol. 2016 Jun 23;233:6-16. doi: 10.1016/j.jbiotec.2016.06.021. [Epub ahead of print]

PMID:
27346232
2.

MUC5B silencing reduces chemo-resistance of MCF-7 breast tumor cells and impairs maturation of dendritic cells.

García EP, Tiscornia I, Libisch G, Trajtenberg F, Bollati-Fogolín M, Rodríguez E, Noya V, Chiale C, Brossard N, Robello C, Santiñaque F, Folle G, Osinaga E, Freire T.

Int J Oncol. 2016 May;48(5):2113-23. doi: 10.3892/ijo.2016.3434. Epub 2016 Mar 10.

PMID:
26984395
3.

Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers.

Ubillos L, Freire T, Berriel E, Chiribao ML, Chiale C, Festari MF, Medeiros A, Mazal D, Rondán M, Bollati-Fogolín M, Rabinovich GA, Robello C, Osinaga E.

Int J Cancer. 2016 Apr 1;138(7):1719-31. doi: 10.1002/ijc.29910. Epub 2015 Nov 20.

PMID:
26519949
4.

Oxidovanadium(IV) complexes with chrysin and silibinin: anticancer activity and mechanisms of action in a human colon adenocarcinoma model.

León IE, Cadavid-Vargas JF, Tiscornia I, Porro V, Castelli S, Katkar P, Desideri A, Bollati-Fogolin M, Etcheverry SB.

J Biol Inorg Chem. 2015 Oct;20(7):1175-91. doi: 10.1007/s00775-015-1298-7. Epub 2015 Sep 24.

PMID:
26404080
5.

Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells.

Núñez de Villavicencio-Díaz T, Ramos Gómez Y, Oliva Argüelles B, Fernández Masso JR, Rodríguez-Ulloa A, Cruz García Y, Guirola-Cruz O, Perez-Riverol Y, Javier González L, Tiscornia I, Victoria S, Bollati-Fogolín M, Besada Pérez V, Guerra Vallespi M.

Data Brief. 2015 Jul 8;4:468-73. doi: 10.1016/j.dib.2015.06.024. eCollection 2015 Sep.

6.

Characterization of Oct4-GFP transgenic mice as a model to study the effect of environmental estrogens on the maturation of male germ cells by using flow cytometry.

Porro V, Pagotto R, Harreguy MB, Ramírez S, Crispo M, Santamaría C, Luque EH, Rodríguez HA, Bollati-Fogolín M.

J Steroid Biochem Mol Biol. 2015 Nov;154:53-61. doi: 10.1016/j.jsbmb.2015.06.006. Epub 2015 Jul 4.

PMID:
26151743
7.

Quantitation of yeast cell-cell fusion using multicolor flow cytometry.

Salzman V, Porro V, Bollati-Fogolín M, Aguilar PS.

Cytometry A. 2015 Sep;87(9):843-54. doi: 10.1002/cyto.a.22701. Epub 2015 May 28.

PMID:
26033928
8.

Comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells.

Núñez de Villavicencio-Díaz T, Ramos Gómez Y, Oliva Argüelles B, Fernández Masso JR, Rodríguez-Ulloa A, Cruz García Y, Guirola-Cruz O, Perez-Riverol Y, Javier González L, Tiscornia I, Victoria S, Bollati-Fogolín M, Besada Pérez V, Guerra Vallespi M.

J Proteomics. 2015 Aug 3;126:163-71. doi: 10.1016/j.jprot.2015.05.024. Epub 2015 May 24.

PMID:
26013411
9.

Human Plasmacytoid Dendritic Cells Elicited Different Responses after Infection with Pathogenic and Nonpathogenic Junin Virus Strains.

Negrotto S, Mena HA, Ure AE, Jaquenod De Giusti C, Bollati-Fogolín M, Vermeulen EM, Schattner M, Gómez RM.

J Virol. 2015 Jul;89(14):7409-13. doi: 10.1128/JVI.01014-15. Epub 2015 Apr 29.

10.

HT-29 and Caco-2 reporter cell lines for functional studies of nuclear factor kappa B activation.

Mastropietro G, Tiscornia I, Perelmuter K, Astrada S, Bollati-Fogolín M.

Mediators Inflamm. 2015;2015:860534. doi: 10.1155/2015/860534. Epub 2015 Mar 10.

11.

Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model.

León IE, Porro V, Astrada S, Egusquiza MG, Cabello CI, Bollati-Fogolin M, Etcheverry SB.

Chem Biol Interact. 2014 Oct 5;222:87-96. doi: 10.1016/j.cbi.2014.10.012. Epub 2014 Oct 22.

PMID:
25451568
12.

Antitumor efficacy, pharmacokinetic and biodistribution studies of the anticancer peptide CIGB-552 in mouse models.

Vallespí MG, Pimentel G, Cabrales-Rico A, Garza J, Oliva B, Mendoza O, Gomez Y, Basaco T, Sánchez I, Calderón C, Rodriguez JC, Markelova MR, Fichtner I, Astrada S, Bollati-Fogolín M, Garay HE, Reyes O.

J Pept Sci. 2014 Nov;20(11):850-9. doi: 10.1002/psc.2676. Epub 2014 Jul 20.

PMID:
25044757
13.

Evaluation of hexane and ethyl acetate extracts of the sponge Jaspis diastra collected from Mauritius Waters on HeLa cells.

Beedessee G, Ramanjooloo A, Tiscornia I, Cresteil T, Raghothama S, Arya D, Rao S, Gowd KH, Bollati-Fogolin M, Marie DE.

J Pharm Pharmacol. 2014 Sep;66(9):1317-27. doi: 10.1111/jphp.12256. Epub 2014 Apr 24.

PMID:
24758528
14.

The transcriptional activities and cellular localization of the human estrogen receptor alpha are affected by the synonymous Ala87 mutation.

Fernández-Calero T, Astrada S, Alberti A, Horjales S, Arnal JF, Rovira C, Bollati-Fogolín M, Flouriot G, Marin M.

J Steroid Biochem Mol Biol. 2014 Sep;143:99-104. doi: 10.1016/j.jsbmb.2014.02.016. Epub 2014 Mar 4.

PMID:
24607813
15.

A new approach for the characterization of proliferative cells in cestodes.

Domínguez MF, Koziol U, Porro V, Costábile A, Estrade S, Tort J, Bollati-Fogolin M, Castillo E.

Exp Parasitol. 2014 Mar;138:25-9. doi: 10.1016/j.exppara.2014.01.005. Epub 2014 Jan 24.

PMID:
24468551
16.

Antiproliferative and apoptosis-inducing activity of an oxidovanadium(IV) complex with the flavonoid silibinin against osteosarcoma cells.

Leon IE, Porro V, Di Virgilio AL, Naso LG, Williams PA, Bollati-Fogolín M, Etcheverry SB.

J Biol Inorg Chem. 2014 Jan;19(1):59-74.

PMID:
24233155
17.

Mucin-like peptides from Echinococcus granulosus induce antitumor activity.

Noya V, Bay S, Festari MF, García EP, Rodriguez E, Chiale C, Ganneau C, Baleux F, Astrada S, Bollati-Fogolín M, Osinaga E, Freire T.

Int J Oncol. 2013 Sep;43(3):775-84. doi: 10.3892/ijo.2013.2000. Epub 2013 Jun 28.

PMID:
23817837
18.

Antitumor properties of a vanadyl(IV) complex with the flavonoid chrysin [VO(chrysin)2EtOH]2 in a human osteosarcoma model: the role of oxidative stress and apoptosis.

Leon IE, Di Virgilio AL, Porro V, Muglia CI, Naso LG, Williams PA, Bollati-Fogolin M, Etcheverry SB.

Dalton Trans. 2013 Sep 7;42(33):11868-80. doi: 10.1039/c3dt50524c.

PMID:
23760674
19.

Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer.

Mazal D, Lo-Man R, Bay S, Pritsch O, Dériaud E, Ganneau C, Medeiros A, Ubillos L, Obal G, Berois N, Bollati-Fogolin M, Leclerc C, Osinaga E.

Cancer Immunol Immunother. 2013 Jun;62(6):1107-22. doi: 10.1007/s00262-013-1425-7. Epub 2013 Apr 21.

PMID:
23604173
20.

The Antitumor Peptide CIGB-552 Increases COMMD1 and Inhibits Growth of Human Lung Cancer Cells.

Fernández Massó JR, Oliva Argüelles B, Tejeda Y, Astrada S, Garay H, Reyes O, Delgado-Roche L, Bollati-Fogolín M, Vallespí MG.

J Amino Acids. 2013;2013:251398. doi: 10.1155/2013/251398. Epub 2013 Jan 16.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk